Targeted delivery of DNA encoding cytotoxic proteins through high-affinity fibroblast growth factor receptors

Human Gene Therapy

Volumn 9, Issue 17, 1998, Pages 2565-2575

  Hoganson, Diana K ^a   Chandler, Lois A ^a   Fleurbaaij, Graham A ^a   Ying, Wenbin ^a   Black, Margaret E ^b   Doukas, John ^a   Pierce, Glenn F ^a   Baird, Andrew ^a   Sosnowski, Barbara A ^a  

^a Selective Genetics Inc   (United States)

^b Chiroscience R and D Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BASIC FIBROBLAST GROWTH FACTOR; CYTOTOXIC FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GANCICLOVIR; HISTONE H1; SAPORIN; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; CELL KILLING; CELL STRAIN 3T3; CELL STRAIN BHK; CODON; ENDOCYTOSIS; GENE TARGETING; GENE THERAPY; HERPES SIMPLEX VIRUS; LIGAND BINDING; NONHUMAN; RECEPTOR AFFINITY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CELL SURVIVAL; CELL-FREE SYSTEM; CRICETINAE; DNA; DNA, COMPLEMENTARY; IMMUNOTOXINS; MOLECULAR SEQUENCE DATA; N-GLYCOSYL HYDROLASES; PLANT PROTEINS; RECEPTORS, FIBROBLAST GROWTH FACTOR; RIBOSOMES; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION;

ANIMALIA; HERPES; MAMMALIA; SIMPLEXVIRUS;

EID: 0032553650     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349850019409     Document Type: Article

References (48)

1. AMALRIC, F., BOUCHE, G., BONNET, H., BRETHENOU, P., ROMAN, A.M., TRUCHET, I., and QUARTO, N. (1994). Fibroblast growth factor-2 (FGF-2) in the nucleus: Translocation process and targets. Biochem. Pharmacol. 47, 111-115.
2. ARNER, E.S.J., SPASOKOUKOTSKAJA, T., and ERIKSSON, S. (1992). Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem. Biophys. Res. Commun. 188, 712-718.
3. BALDIN, V., ROMAN, A.M., BOSC BIERNEI, I., AMALRIC, F., and BOUCHE, G. (1990). Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J. 9, 1511-1517.
4. BARTHELEMY, I., MARTINEAU, D., ONG, M., MATSUNAMI, R., LING, N., BENATTI, L., CAVALLARO, U., SORIA, M., and LAPPI, D.A. (1993). The expression of saporin, a ribosome-inactivating protein from the plant Saponaria officinalis, in Escherichia coll. J. Biol. Chem. 268, 6541-6548.
5. BASILICO, C., and MOSCATELLI, D. (1992). The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59, 115-163.
6. BEITZ, J.G., DAVOL, P., CLARK, J.W., KATO, J., MEDINA, M., FRACKELTON, A.R., JR., LAPPI, D.A., BAIRD, A., and CALABRESI, P. (1992). Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo. Cancer Res. 52, 227-230.
7. BENATTI, L., SACCARDO, M.B., DANI, M., NITTI, G., SASSANO, M., LORENZETTI, R., LAPPI, D.A., and SORIA, M. (1989). Nucleotide sequence of cDNA coding for saporin-6, a type-1 ribosome-inactivating protein from Saponaria officinalis. Eur. J. Biochem. 183, 465-470.
8. BI, W.L., PARYSEK, L.M., WARNICK, R., and STAMBROOK, P.J. (1993). In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther. 4, 725-731.
9. BLACK, M.E., NEWCOMB, T.G., WILSON, H.M., and LOEB, L.A. (1996). Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 93, 3525-3629.
10. CASSCELLS, W., LAPI, D.A., OLWIN, B.B., WAI, C., SIEGMAN, M., SPEIR, E.H., SASSE, J., and BAIRD, A. (1992). Elimination of smooth muscle cells in experimental restenosis: Targeting of fibroblast growth factor receptors. Proc. Natl. Acad. Sci. U.S.A. 89, 7159-7163.
11. CHEN, J., GAMOU, S., TAKAYANAGI, A., and SHIMIZU, N. (1994). A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS Lett. 338, 167-169.
12. COTTEN, M., LANGLE ROUAULT, F., KIRLAPPOS, H., WAGNER, E., MECHTLER, K., ZENKE, M., BEUG, H., and BIRSTIEL, M.L. (1990). Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc. Natl. Acad. Sci. U.S.A. 87, 4033-4037.
13. CRISTIANO, R.J., and CURIEL, D.T. (1996). Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway. Cancer Gene Ther. 3, 49-57.
14. CRISTIANO, R.J., and ROTH, J.A. (1996). Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Ther. 3, 4-10.
15. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
16. FREEMAN, S.M., WHARTENBY, K.A., FREEMAN, J.L., ABBOUD, C.N., and MARROGI, A.J. (1996). In situ use of suicide genes for cancer therapy. Semin. Oncol. 23, 31-45.
17. GOSPODAROWICZ, D., and CHENG, J. (1986). Heparin protects basic and acidic FGF from inactivation. J. Cell Physiol. 128, 475-484.
18. GOTTSCHALK, S., CRISTIANO, R.J., SMITH, L.C., and WOO, S.L. (1994). Folate receptor mediated DNA delivery into tumor cells: Potosomal disruption results in enhanced gene expression. Gene Ther. 1, 185-191.
19. GUY, J., DRABEK, D., and ANTONIOU, M. (1995). Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy. Mol. Biotechnol. 3, 237-248.
20. HART, S.L., HARBOTTLE, R.P., COOPER, R., MILLER, A., WILLIAMSON, R., and COUTELLE, C. (1995). Gene delivery and expression mediated by an integrin-binding peptide. Gene Ther. 2, 552-554.
21. HUCKETT, B., ARIATTI, M., and HAWTREY, A.O. (1990). Evidence for targeted gene transfer by receptor-mediated endocytosis. Stable expression following insulin-directed entry of NEO into HepG2 cells. Biochem. Pharmacol. 40, 253-263.
22. KASAHARA, N., DOZY, A.M., and KAN, Y.W. (1994). Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373-1375.
23. KINGSTON, R.E. (1998). Introduction of DNA into mammalian cells. In: Current Protocols in Molecular Biology. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, eds. (John Wiley & Sons, New York), pp. 9.0.1-9.1.11.
24. KOZAK, M. (1987). An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125-8148.
25. LAPPI, D.A., MATSUNAMI, R., MARTINEAU, D., and BAIRD, A. (1993). Reducing the heterogeneity of chemically conjugated targeted toxins: Homogeneous basic FGF-saporin. Anal. Biochem. 212, 446-451.
26. MATTHEWS, T., and BOEHME, R. (1988). Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 10, S490-S514.
27. McDONALD, J.R., ONG, M., SHEN, C., PARANDOOSH, Z., SOSNOWSKI, B.A., BUSSELL, S., and HOUSTON, L.L. (1996). Large-scale purification and characterization of recombinant fibroblast growth factor-saporin mitotoxin. Protein Express. Purif. 8, 97-108.
28. MIDOUX, P., MENDES, C., LEGRAND, A., RAIMOND, J., MAYER, R., MONSIGNY, M., and ROCHE, A.C. (1993). Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. Nucleic Acids Res. 21, 871-878.
29. MOOLTEN, F.L. (1986). Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 46, 5276-5281.
30. MOSCATELLI, D. (1992). Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. J. Biol. Chem. 267, 25803-25809.
31. NEUFELD, G., and GOSPODAROWICZ, D. (1985). The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J. Biol. Chem. 260, 13860-13868.
32. QUARTO, N., TALARICO, D., FLORKIEWICZ, R., and RIFKIN, D.B. (1991). Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells. Cell Regul. 2, 699-708.
33. RENCO, M., QUARTO, N., MORIMOTO, T., and RIFKIN, D.B. (1989). Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J. Cell. Physiol. 144, 108-114.
34. ROGHANI, M., and MOSCATELLI, D. (1992). Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J. Biol. Chem. 267, 22156-22162.
35. ROSENKRANZ, A.A., YACHMENEV, S.V., JANS, D.A., SEREBRYAKOVA, N.V., MURAV'EV, V.I., PETERS, R., and SOBOLEV, A.S. (1992). Receptor-mediated endocytosis and nuclear transport of a transfecting DNA construct. Exp. Cell Res. 199, 323-329.
36. ROTH, J.A., and CRISTIANO, R.J. (1997). Gene therapy for cancer: What have we done and where are we going? J. Natl. Cancer Inst. 89, 21-39.
37. SCHWARTZ, A.L., FRIDOVICH, S.E., KNOWLES, B.B., and LODISH, H.F. (1981). Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J. Biol. Chem. 256, 8878-8881.
38. SOSNOWSKI, B.A., GONZALEZ, A.M., CHANDLER, L.A., BUECHLER, Y.J., PIERCE, G.F., and BAIRD, A. (1996). Targeting DNA to cells with basic fibroblast growth factor (FGF2). J. Biol. Chem. 271, 33647-33653.
39. STEVENSON, S.C., ROLLENCE, M., MARSHAEL-NEFF, J. and McCLEELAND, A. (1997). Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J. Virol. 71, 4782-4790.
40. VILE, R.G., and HART, I.R. (1993). Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res. 53, 3860-3864.
41. WAGNER, E., ZENKE, M., COTTEN, M., BEUG, H., and BIRNSTIEL, M.L. (1990). Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. U.S.A. 87, 3410-3414.
42. WAGNER, E., COTTEN, M., FOISNER, R., and BIRNSTIEL, M.L. (1991). Transferrin-polycation-DNA complexes: The effect of polycations on the structure of the complex and DNA delivery to cells. Proc. Natl. Acad. Sci. U.S.A. 88, 4255-4259.
43. WAGNER, E., ZATLOUKAL, K., COTTEN, M., KIRLAPPOS, H., MECHTLER, K., CURIEL, D.T., and BIRNSTIEL, M.L. (1992). Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. U.S.A. 89, 6099-6103.
44. WALICKE, P.A., and BAIRD, A. (1991). Internalization and processing of basic fibroblast growth factor by neurons and astrocytes. J. Neurosci. 11, 2249-2258.
45. WU, G.Y., WILSON, J.M., SHALABY, F., GROSSMAN, M., SHAFRITZ, D.A., and WU, C.H. (1991). Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. J. Biol. Chem. 266, 14338-14342.
46. WU, J.K., CANO, W.G., MEYLAERTS, S.A., QI, P., VRIONIS, F., and CHERINGTON, V. (1994). Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery 35, 1094-1103.
47. YAMAIZUMI, M., MEKADA, E., UCHIDA, T., and OKADA, Y. (1978). One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 15, 245-250.
48. YING, W., MARTINEAU, D., BEITZ, J., LAPPI, D.A., and BAIRD, A. (1994). Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin. Cancer 74, 848-853.